HOOK Stock Summary and Trading Ideas (Hookipa Pharma | NASDAQ:HOOK)

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Hookipa Pharma trades on the NASDAQ stock market under the symbol HOOK.

As of May 17, 2024, HOOK stock price climbed to $0.82 with 259,681 million shares trading.

HOOK has a beta of 1.77, meaning it tends to be more sensitive to market movements. HOOK has a correlation of 0.09 to the broad based SPY ETF.

HOOK has a market cap of $80.68 million. This is considered a Micro Cap stock.

Last quarter Hookipa Pharma reported $37 million in Revenue and $.11 earnings per share. This beat revenue expectation by $34 million and exceeded earnings estimates by $.21.

In the last 3 years, HOOK stock traded as high as $20.00 and as low as $.41.

The top ETF exchange traded funds that HOOK belongs to (by Net Assets): VTI, VXF, IWC.

HOOK has underperformed the market in the last year with a price return of -44.9% while the SPY ETF gained +29.1%. However, in the short term, HOOK had mixed performance relative to the market. It has outperformed in the last 3 months, returning +23.4% vs +6.3% return in SPY. But in the last 2 weeks, HOOK shares have been beat by the market, returning -12.3% compared to an SPY return of +3.6%.

HOOK support price is $.76 and resistance is $.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HOOK stock will trade within this expected range on the day.